Pacira Pharm Inc (PCRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 78,228 | 132,526 | 54,126 | 35,944 | 56,984 |
| Marketable Securities | 213,722 | 250,928 | 257,221 | 136,653 | 101,981 |
| Receivables | 47,530 | 38,000 | 31,658 | 29,937 | 25,855 |
| Inventories | 58,296 | 48,569 | 41,411 | 31,278 | 61,645 |
| TOTAL | $408,557 | $477,969 | $391,110 | $243,089 | $252,582 |
| Non-Current Assets | |||||
| PPE Net | 104,681 | 108,670 | 107,046 | 101,016 | 90,324 |
| Investments And Advances | 75,769 | 40,674 | 74,193 | 0 | 13,462 |
| Intangibles | 203,934 | 62,040 | 55,197 | 46,737 | 30,961 |
| Other Non-Current Assets | 38,124 | 0 | 825 | 624 | 406 |
| TOTAL | $422,508 | $211,384 | $237,261 | $148,377 | $135,153 |
| Total Assets | $831,065 | $689,353 | $628,371 | $391,466 | $387,735 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 12,799 | 14,368 | 14,658 | 7,511 | 8,739 |
| Accrued Expenses | 70,427 | 45,865 | 41,057 | 36,666 | 35,375 |
| Other current liabilities | 18,179 | N/A | N/A | N/A | N/A |
| TOTAL | $107,673 | $60,661 | $56,217 | $44,838 | $149,788 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | N/A | 102 | 595 | 1,426 |
| Other Non-Current Liabilities | 368,448 | 307,466 | 292,671 | 127,652 | 11,473 |
| TOTAL | $368,448 | $307,466 | $292,671 | $127,652 | $19,555 |
| Total Liabilities | $476,121 | $368,127 | $348,888 | $172,490 | $169,343 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 42,033 | 41,230 | 40,712 | 37,525 | 37,053 |
| Common Shares | 42 | 41 | 41 | 37 | 37 |
| Retained earnings | -399,398 | -388,226 | -389,136 | -346,238 | -308,289 |
| Other shareholders' equity | 322 | -280 | -454 | -30 | -52 |
| TOTAL | $354,944 | $321,226 | $279,483 | $218,976 | $218,392 |
| Total Liabilities And Equity | $831,065 | $689,353 | $628,371 | $391,466 | $387,735 |